CRM vs IBM
CRM and IBM side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CRMSalesforce, Inc. | IBMINTERNATIONAL BUSINESS MACHINES CORPORATION |
|---|---|---|
| Market cap | $188.59B | $243.69B |
| P/E (TTM) | 21.0 | 21.9 |
| P/B | 4.91 | 6.86 |
| P/S | 4.5x | 3.6x |
| Dividend yield | 0.84% | 2.57% |
| Revenue | $43.94B(TTM) | $69.87B(TTM) |
| Revenue growth (YoY) | 9.6% | 7.6% |
| Net income | $9.66B(TTM) | $11.17B(TTM) |
| Earnings growth (YoY) | 20.3% | 75.9% |
| EPS, diluted | $10.92(TTM) | $11.75(TTM) |
| EBIT margin | 20.1% | 18.2% |
| ROE | 19.4% | 29.8% |
| ROIC | 9.4% | 13.2% |
| Piotroski F | 6/9 | 7/9 |
| 1y total return | -10.0% | -14.8% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CRM frente a IBM
| Métrica | CRM | IBM |
|---|---|---|
| Valor final | $29.6K | $26.6K |
| Retorno total | +195.6% | +165.6% |
| CAGR | +11.1% | +9.9% |
| Volatilidad | 36.2% | 28.2% |
| Sharpe | 0.36 | 0.33 |
| Sortino | 0.52 | 0.46 |
| Caída máxima | -58.7% | -40.6% |
Basado en 2600 días de negociación comunes, 2016-06-29 → 2026-10-30 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)